MedTrace Logo

A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer

NCT02745197 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2024-09-19

No results posted yet for this study

Summary

This study evaluates a nutritional supplement in the treatment of pancreatic cancer in adults. Half of the participants will receive the nutritional supplement, while the other half will receive a placebo.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nutritional Supplement

Participants will take 2 capsules, containing the nutritional supplement, 3 times per day.

DIETARY_SUPPLEMENT

Placebo

Participants will take 2 capsules, containing a placebo, 3 times per day.

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Vera Mazurak, Ph.D. · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-31
Primary Completion
2018-10-31
Completion
2018-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745197 on ClinicalTrials.gov